Pharma & life sciences · Research CISO · Intellectual Property Counsel · Data Platform
Prioritize harvest-now-decrypt-later risk in drug-discovery data
Which target, compound, genomic, and partnership datasets retain economic value past current encryption assumptions?
Operational pain
Research repositories are classified by project secrecy but rarely by confidentiality horizon and the cryptography protecting transfers, notebooks, backups, and partner exchanges.
Trigger
A strategic research partnership, data-lake consolidation, or quantum-readiness programme.
QNSI contribution
Connect the decision to a controlled security path
Join QNSI crypto discovery with data owners, patent milestones, collaboration paths, and sensitivity duration.
Decision artifact
An R&D quantum-exposure portfolio ranking datasets by value horizon, capture surface, and remediation option.
What still requires validation
Research and legal owners decide data value, export controls, collaboration constraints, and acceptable re-protection methods.
External problem context
Primary sources
These sources establish the external requirement or risk context. They do not endorse HEOSSI or prove that QNSI completed this scenario.
Evidence boundary
What this page does—and does not—prove
This is a product evaluation pattern, not a customer case study, certification, legal opinion, regulator endorsement, or claim that a production deployment completed the described work.